Login / Signup

Safety and efficacy of low-dose diazoxide in small-for-gestational-age infants with hyperinsulinaemic hypoglycaemia.

Suresh ChandranPravin R RMei Chien ChuaSeyed Ehsan SaffariVictor Samuel RajaduraiFabian Yap
Published in: Archives of disease in childhood. Fetal and neonatal edition (2021)
Our study demonstrates that low-dose DZX effectively treats SGA infants with HH as measured by fasting studies. Although the safety profile was excellent, minimal adverse events were still observed with DZX, even at low doses.
Keyphrases
  • low dose
  • gestational age
  • birth weight
  • high dose
  • preterm birth
  • type diabetes
  • insulin resistance
  • blood glucose
  • physical activity
  • adipose tissue
  • glycemic control